MoonLake Immunotherapeutics GAAP EPS of -$0.93 misses by $0.15

MoonLake Immunotherapeutics reports Q3 GAAP EPS miss at -$0.93, falling short by $0.15.

CryptoAlerta — análise de criptomoedas e mercado em tempo real